Improving Outcomes in SCLC Through Optimal Integration of the Latest Therapies: Expert Perspectives

Assessing the Impact of Therapeutic Advances in SCLCПодробнее

Integrating New Options Into the SCLC Treatment Arsenal to Improve Patient OutcomesПодробнее

Optimal Management of Limited-Stage SCLCПодробнее

Improving Outcomes in Molecularly Altered NSCLC Through Precision Testing and TreatmentПодробнее

How can treatment outcomes in limited-stage SCLC be improved?Подробнее

Progress on the Path to Improving Outcomes in the Treatment of SCLCПодробнее

Improving outcomes in NSCLC with perioperative targeted therapiesПодробнее

Facilitating Progress in the Treatment of SCLCПодробнее

Optimizing NSCLC treatment with biomarker testing insightsПодробнее

Dr. Garon Discusses Driver Mutations in SCLCПодробнее

Frontline I-O Strategies in SCLC: Practical ImplicationsПодробнее

Expert Perspective | New and Emerging Progress in Lung Cancer TreatmentПодробнее

Case Based Panel Discussion | Dr Bhuvan Chug | Optimal management of ES SCLCПодробнее

Treatment of Relapsed/Refractory SCLCПодробнее

Tiffany Varughese, PharmD: SCLC Current Standard of Care and Emerging TherapiesПодробнее

Optimizing precision medicine in NSCLCПодробнее

Watch Drs. Owonikoko, Gay, & Sands discuss #SCLC - https://bit.ly/3S7IUiqПодробнее

Optimal SCLC Care With Established and Innovative TherapiesПодробнее

Impact of severe esophagitis on outcomes in radiotherapy-treated LS SCLCПодробнее